BHCM

Brevan Howard Capital Management Portfolio holdings

AUM $10B
1-Year Est. Return 35.86%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+35.86%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$10B
AUM Growth
+$4.8B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
2,461
New
Increased
Reduced
Closed

Top Buys

1
+$887M
2
+$812M
3
+$670M
4
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$516M
5
NVDA icon
NVIDIA
NVDA
+$451M

Top Sells

1
+$452M
2
+$147M
3
+$135M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$112M
5
WMT icon
Walmart Inc
WMT
+$89.8M

Sector Composition

1 Technology 15.57%
2 Consumer Discretionary 11.55%
3 Financials 8.62%
4 Industrials 6.15%
5 Communication Services 4.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WSBC icon
2001
WesBanco
WSBC
$3.31B
– –
-9,781
WSC icon
2002
WillScot Mobile Mini Holdings
WSC
$4.74B
– –
-10,037
WST icon
2003
West Pharmaceutical
WST
$22.2B
– –
-9,108
WTI icon
2004
W&T Offshore
WTI
$550M
– –
-10,995
XLK icon
2005
State Street Technology Select Sector SPDR ETF
XLK
$117B
– –
0
YUM icon
2006
Yum! Brands
YUM
$41.6B
– –
-11,418
WYNN icon
2007
Wynn Resorts
WYNN
$10.8B
– –
-2,220
XHB icon
2008
State Street SPDR S&P Homebuilders ETF
XHB
$1.53B
– –
0
Z icon
2009
Zillow
Z
$8.02B
– –
-16,612
ZYME icon
2010
Zymeworks
ZYME
$1.77B
– –
-23,333
PACS icon
2011
PACS Group
PACS
$5.86B
– –
-9,167
TLN
2012
Talen Energy Corp
TLN
$16.6B
– –
-1,000
LIF
2013
Life360
LIF
$3.68B
– –
-9,597
RAPP
2014
Rapport Therapeutics
RAPP
$1.73B
– –
-16,783
GRAL
2015
GRAIL Inc
GRAL
$2.57B
– –
-11,320
ETHA
2016
iShares Ethereum Trust ETF
ETHA
$4.68B
– –
-289,408
GAP
2017
The Gap Inc
GAP
$7.76B
– –
-111,112
ORKA
2018
Oruka Therapeutics
ORKA
$3.63B
– –
-9,416
SEI
2019
Solaris Energy Infrastructure
SEI
$4.05B
– –
-20,603
BCAX
2020
Bicara Therapeutics
BCAX
$1.31B
– –
-14,117
MBX
2021
MBX Biosciences
MBX
$1.44B
– –
-25,663
ZBIO
2022
Zenas BioPharma
ZBIO
$1.1B
– –
-6,173
CURB
2023
Curbline Properties
CURB
$3.09B
– –
-15,647
VENU
2024
Venu Holding Corp
VENU
$195M
– –
0
PVLA
2025
Palvella Therapeutics
PVLA
$1.56B
– –
-5,740
79 80
81
82 83